Skip to main content
ABIVAX logo

ABIVAX — Investor Relations & Filings

Ticker · ABVX ISIN · FR0012333284 LEI · 969500D8TMNB184OJU95 PA Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2016-10-10 Share Issue/Capital Cha…
Country FR France
Listing PA ABVX

About ABIVAX

https://www.abivax.com

Abivax is a clinical-stage biotechnology company developing therapeutics for chronic inflammatory diseases by regulating the immune system. The company's scientific approach is centered on harnessing microRNA (miRNA) biology. Its lead drug candidate, obefazimod, is an investigational, once-daily, oral small molecule with a novel mechanism of action that enhances the expression of miR-124, a natural regulator of the inflammatory response. The primary development program for obefazimod focuses on ulcerative colitis, for which the company has reported positive Phase 3 clinical trial results. Abivax is also investigating the candidate for the treatment of Crohn's disease and other inflammatory conditions, while exploring follow-on compounds.

Recent filings

Filing Released Lang Actions
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 1% confidence The document is titled "Publication du nombre d'actions composant le capital social et du nombre total de droits de vote" (Publication of the number of shares comprising the share capital and the total number of voting rights). It explicitly references French regulatory articles (L. 233-8 II du code de commerce and article 223-16 du règlement général de l'Autorité des marchés financiers - AMF). This type of mandatory disclosure, detailing the total share count and voting rights as of a specific date (30/09/2016), is a standard regulatory filing in France. While it relates to capital structure, it is not a general financing announcement (CAP) or a share issue/repurchase report (SHA/POS). It is a specific, periodic regulatory disclosure concerning ownership structure and voting power. Given the options, this specific disclosure about voting rights and share capital count fits best under the general regulatory announcement category, 'Regulatory Filings' (RNS), as it is a mandatory disclosure that doesn't align perfectly with the more specific financial report types (like 10-K, IR, ER) or corporate actions (like DIV, SHA). It is a formal regulatory update.
2016-10-10 French
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Report Publication Announcement Classification · 1% confidence The document is titled "Publication d'une lettre aux actionnaires" (Publication of a Letter to Shareholders) and explicitly states that the company 'annonce aujourd'hui la publication d'une Lettre aux Actionnaires' (announces today the publication of a Letter to Shareholders). The text is short (1952 characters) and serves primarily to announce the availability of the actual letter on their website, rather than containing the full content of the letter itself. According to Rule 2 (The 'MENU VS MEAL' Rule), a short announcement stating a report has been published points towards a Report Publication Announcement (RPA). While 'LTR' (Legal Proceedings Report) is not applicable, and 'IR' (Interim Report) is not the primary focus, the action described is the announcement of a publication.
2016-10-04 French
Communicated under the obligation to provide permanent information / Other communications
Report Publication Announcement Classification · 1% confidence The document is titled "Publication of a shareholder newsletter" and explicitly states that the company "announces the publication of a shareholder newsletter that provides an update on the major achievements of the first half of 2016." It then directs the reader to the website to find the newsletter. This structure—a short announcement stating that a report/document has been published and is available elsewhere—fits the definition of a Report Publication Announcement (RPA). It is not the newsletter itself, but the announcement of its release. The document length (1932 chars) is also short, supporting the RPA classification over a comprehensive report like IR or 10-K.
2016-10-04 English
ABIVAX veroffentlicht Aktionarsbrief
Report Publication Announcement Classification · 1% confidence The document is a short news release dated October 4, 2016, titled "ABIVAX veröffentlicht Aktionärsbrief" (ABIVAX publishes Shareholder Letter). It explicitly states that the shareholder letter, which provides an overview of the first half of 2016 events, is available for download on the company website and provides a direct link. Since the document itself is an announcement about the publication of a report (the shareholder letter) rather than the full report content, and given its short length (3205 chars), it fits the definition of a Report Publication Announcement (RPA).
2016-10-04 German
Communiqués au titre de l'obligation d'information permanente / Activité de l'émetteur (acquisitions, cessions, partenariats, …)
Regulatory Filings Classification · 1% confidence The document is a press release dated September 22, 2016, announcing the inauguration of a cooperative laboratory between ABIVAX and CNRS in Montpellier. It details a partnership, research activities, and the status of a drug candidate (ABX464). This type of announcement, which communicates a significant business development, partnership, or operational milestone, does not fit neatly into the specific financial reporting categories (10-K, ER, IR, etc.). It is a general corporate announcement. Since it is not a standard regulatory filing like a Director's Dealing (DIRS) or a Major Shareholding Notification (MRQ), and it's not a transcript (CT) or a presentation (IP), the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general category for miscellaneous corporate announcements that are not covered by more specific codes.
2016-09-22 French
Rapport financier semestriel
Interim / Quarterly Report Classification · 1% confidence The document is a 'Rapport Financier Semestriel' (Half-Year Financial Report) for the period ending June 30, 2016. It contains detailed financial statements (balance sheet, income statement, cash flow, and equity changes), management commentary on business activities, and audit information. It is a comprehensive interim report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). H2 2016
2016-09-21 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.